Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Пациент с головокружением – оптимизация терапии
Пациент с головокружением – оптимизация терапии
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Gil-Loyzaga P. Neurotransmitters of the olivocochlear lateral efferent system: with an emphasis on dopamine. Acta Otolaryngol 1995; 115 (2): 222–6.
2. Никифоров А.С., Коновалов А.Н., Гусев Е.И. Клин. неврология. М.: Медицина, 2002.
3. Brevern M, Radtke A, Lezius F et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry 2007; 78: 710–5.
4. Baloh R. Dizziness, hearing loss, and tinnitus. New York: Oxford University Press, 1998; p. 107–25.
5. Refoyo P, Plasencia P, Mateos B. Ischemia of the anterior vestibular artery (Lindsay-Hemenway syndrome). Review and comments. Acta Otorrinolaringol Esp 1998; 49 (8): 599–602.
6. Halmagyi GM. Diagnosis and management of vertigo. Clin Med 2005; 5 (2): 159–65.
7. Табеева Г.Р., Вейн А.М. Головокружение при психовегетативных синдромах Cons. Med. 2001; 4 (15): 41–6.
8. Brandt T, Kapfhammer H, Dieterich M. «Phobic postural vertigo». A further differentiation of psychogenic vertigo conditions seems necessary. Nervenarzt 1997; 68 (10): 848–9.
9. Colledge N, Wilson J, Macintyre C, MacLennan W. The prevalence and characteristics of dizziness in an elderly community. Age Aging 1994; 23: 117–20.
10. Fraysse B, Bebear J, Dubreuil C. Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease. Acta Otolaryngol 1991; Suppl. 490: 1–6.
11. Albera R, Ciuffolotti R, Di Cicco M. Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 2003; 123 (5): 588–93.
12. Cavaliere M, Mottola G, Iemma M. Benign paroxysmal positional vertigo: a study of two maneuvers with and without betahistine. Acta Otorhinolaryngol Ital 2005; 25 (2): 107–12.
13. Mira E, Guidetti G, Ghilardi L. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur Arch Otorhinolaryngol 2003; 260 (2): 73–7.
14. Aantaa E. Treatment of acute vestibular vertigo. Acta Otolaryngol (Stockh) 1991; Suppl. 479: 44–7.
15. Claes J, Van De Heyning PH. A review of medical treatment for Meniere's disease Acta Otolaryngol (Stickh) 2000; Suppl. 544: 34–9.
16. Djelilovic-Vranic J, Alajbegovic A, Tiric-Campara M et al. Betahistine or Cinnarizine for treatment of Meniere's disease. Med Arh 2012; 66 (6): 396–8.
17. Костенко Е.В., Петрова А.В., Торгованова Е.А. и др. Опыт лечения вестибулярного головокружения и синдрома Меньера в амбулаторных условиях. Журн. неврологии и психиатрии им. С.С.Корсакова. 2012; 12: 36–40.
18 Agus S, Benecke H, Thum C, Strupp M. Clinical and Demographic Features of Vertigo: Findings from the REVERT Registry. Front Neurol 2013; 4: 48–53.
19. Nauta J. Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo. Eur Arch Otorhinolaryngol 2013. [Epub ahead of print].
20. Гусев Е.И., Никонов А.А., Скворцова В.И. и др. Лечение головокружений препаратом Бетасерк у больных с сосудистыми и травматическими поражениями головного мозга. Журн. неврологии и психиатрии. 1998; 11: 45–50.
21. Dutia M. Betahistine, vestibular function and compensation: in vitro studies of vestibular function and plasticity. Acta Otolaryngol 2000;
Suppl. 544: 11–4.
22. Tighilet B, Leonard J, Lacour M. Betahistine dihydrochloride treatment facilitates vestibular compensation in the cat. J Vest Res 1995; 5: 53–66.
23. Strupp M, Brandt T. Peripheral vestibular disorders. Curr Opin Neurol 2013; 26 (1): 81–9.
24. Lezius F, Adrion C, Mansmann U et al. High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Menière's disease: a case series. Eur Arch Otorhinolaryngol 2011; 268 (8): 1237–40.
25. Guneri E, Kustutan O. The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2012; 146 (1): 104–8.
2. Никифоров А.С., Коновалов А.Н., Гусев Е.И. Клин. неврология. М.: Медицина, 2002.
3. Brevern M, Radtke A, Lezius F et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry 2007; 78: 710–5.
4. Baloh R. Dizziness, hearing loss, and tinnitus. New York: Oxford University Press, 1998; p. 107–25.
5. Refoyo P, Plasencia P, Mateos B. Ischemia of the anterior vestibular artery (Lindsay-Hemenway syndrome). Review and comments. Acta Otorrinolaringol Esp 1998; 49 (8): 599–602.
6. Halmagyi GM. Diagnosis and management of vertigo. Clin Med 2005; 5 (2): 159–65.
7. Табеева Г.Р., Вейн А.М. Головокружение при психовегетативных синдромах Cons. Med. 2001; 4 (15): 41–6.
8. Brandt T, Kapfhammer H, Dieterich M. «Phobic postural vertigo». A further differentiation of psychogenic vertigo conditions seems necessary. Nervenarzt 1997; 68 (10): 848–9.
9. Colledge N, Wilson J, Macintyre C, MacLennan W. The prevalence and characteristics of dizziness in an elderly community. Age Aging 1994; 23: 117–20.
10. Fraysse B, Bebear J, Dubreuil C. Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease. Acta Otolaryngol 1991; Suppl. 490: 1–6.
11. Albera R, Ciuffolotti R, Di Cicco M. Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 2003; 123 (5): 588–93.
12. Cavaliere M, Mottola G, Iemma M. Benign paroxysmal positional vertigo: a study of two maneuvers with and without betahistine. Acta Otorhinolaryngol Ital 2005; 25 (2): 107–12.
13. Mira E, Guidetti G, Ghilardi L. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur Arch Otorhinolaryngol 2003; 260 (2): 73–7.
14. Aantaa E. Treatment of acute vestibular vertigo. Acta Otolaryngol (Stockh) 1991; Suppl. 479: 44–7.
15. Claes J, Van De Heyning PH. A review of medical treatment for Meniere's disease Acta Otolaryngol (Stickh) 2000; Suppl. 544: 34–9.
16. Djelilovic-Vranic J, Alajbegovic A, Tiric-Campara M et al. Betahistine or Cinnarizine for treatment of Meniere's disease. Med Arh 2012; 66 (6): 396–8.
17. Костенко Е.В., Петрова А.В., Торгованова Е.А. и др. Опыт лечения вестибулярного головокружения и синдрома Меньера в амбулаторных условиях. Журн. неврологии и психиатрии им. С.С.Корсакова. 2012; 12: 36–40.
18 Agus S, Benecke H, Thum C, Strupp M. Clinical and Demographic Features of Vertigo: Findings from the REVERT Registry. Front Neurol 2013; 4: 48–53.
19. Nauta J. Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo. Eur Arch Otorhinolaryngol 2013. [Epub ahead of print].
20. Гусев Е.И., Никонов А.А., Скворцова В.И. и др. Лечение головокружений препаратом Бетасерк у больных с сосудистыми и травматическими поражениями головного мозга. Журн. неврологии и психиатрии. 1998; 11: 45–50.
21. Dutia M. Betahistine, vestibular function and compensation: in vitro studies of vestibular function and plasticity. Acta Otolaryngol 2000;
Suppl. 544: 11–4.
22. Tighilet B, Leonard J, Lacour M. Betahistine dihydrochloride treatment facilitates vestibular compensation in the cat. J Vest Res 1995; 5: 53–66.
23. Strupp M, Brandt T. Peripheral vestibular disorders. Curr Opin Neurol 2013; 26 (1): 81–9.
24. Lezius F, Adrion C, Mansmann U et al. High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Menière's disease: a case series. Eur Arch Otorhinolaryngol 2011; 268 (8): 1237–40.
25. Guneri E, Kustutan O. The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2012; 146 (1): 104–8.
Авторы
П.Р.Камчатнов, А.В.Чугунов, А.Ю.Казаков
Кафедра неврологии и нейрохирургии лечебного факультета ГБОУ ВПО РНИМУ им. Н.И.Пирогова Минздрава России, Москва
Кафедра неврологии и нейрохирургии лечебного факультета ГБОУ ВПО РНИМУ им. Н.И.Пирогова Минздрава России, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.